Media - published on 27 Feb 2020

Hoelang voordat de pillen op zijn?

This article from Liza van Lonkhuyzen of NRC follows the recent coronavirus outbreak and how it can potentially lead to a global antibiotic shortage. The article features findings from the Foundation's white paper on the issues facing the security of antibiotic supply. 

With China being one of the major countries to supply raw materials for medicines, the article dives into the factors that may interrupt the supply chain in the backdrop of the outbreak. 

Speaking to many exerts in the field, the report also uses research from the Foundation's white paper Shortages, stockouts and scarcity: the issues facing the security of antibiotic supply and the role for pharmaceutical companies. Here, it refers to the recent shortage of Benzathine benzylpenicillin (BGP) used for the treatment of syphilis in around 40 countries.


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.

Back to top |